Latest News about VRTX
Recent news which mentions VRTX
Making Sense of Amazon CEO Andy Jassy's Latest Letter
April 22, 2024
From Motley Fool
If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today
April 22, 2024
Tickers
VRTX
From Motley Fool
Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now
April 22, 2024
From Motley Fool
From Motley Fool
3 Relatively Safe Growth Stocks You Can Buy and Hold
April 20, 2024
From Motley Fool
3 Biotech Stocks Set to Double by 2028
April 20, 2024
From InvestorPlace
From Benzinga
From Motley Fool
From Benzinga
From Motley Fool
Could This Stock Be the Next Biotech Buyout?
April 13, 2024
From Motley Fool
Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact
April 11, 2024
From Benzinga
Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday?
April 11, 2024
From Benzinga
From InvestorPlace
From InvestorPlace
From InvestorPlace
From InvestorPlace
Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune
April 11, 2024
From Benzinga
From Benzinga
Tickers
VRTX
From Motley Fool
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'
April 09, 2024
From Benzinga
From InvestorPlace
From Motley Fool
From Motley Fool
From Motley Fool
Meet The "Magnificent Seven" of Healthcare Stocks
April 01, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free